Navigation Links
Compounds In Legume May Be Helpful In Treating Cancer

Researchers at Centre of Excellence for Integrative Legume Research (CILR) have screened legumes, the plants which obtain useable nitrogen from soil bacteria// in their roots, for biological activity and they identified a number of compounds, which could potentially prevent the formation of a blood supply to tumours. Without an adequate blood supply tumours stop growing and ultimately can regress.

The CILR has lodged a complete patent application for compounds to treat cancer.

The research has attracted major international interest for intensive collaboration and joint development.

The discovery has resulted in a formal research collaboration which is currently underway with French "CSIRO-equivalent" Centre National de la Recherche Scientifique. Co-investment discussions are also in progress with a New Zealand company.

The CILR formed a commercialisation business "Meristomics" last October to commercialise plant research discoveries. CILR's partner universities (the University of Queensland, Australian National University, University of Newcastle and University of Melbourne) passed on their commercialisation rights to Uniquest Pty Ltd, the University of Queensland's main commercialisation company.

Meristomics Chief Executive Officer Ian Harris said successful completion of this patent demonstrated that Meristomics was an effective model for commercialisation involving multiple partner universities.

"Through UniQuest, Meristomics had immediate access to substantial commercial expertise and is looking to build on its patent success by attracting further funding to progress the research," Mr Harris said.

The anti-cancer molecules are produced by legumes during the early symbiotic relationship with soil bacteria known as rhizobia. Rhizobia induce legumes to form tiny new root organs called "root nodules." The bacteria live in the nodules and provide the plant with useable nitrogen it can convert into proteins.

CILR Chief Investigator Professor Chris Parish's group, based at ANU's John Curtin School of Medical Research, developed the bioassay used to identify the compounds as potential therapeutic agents.

"We have identified several compounds derived from the legume interaction with rhizobium bacteria that show strong anti-angiogenic activity.

"They are promising therapeutic molecules which clearly warrant further investigation," Professor Parish said.

CILR Director Professor Peter Gresshoff said the current research success highlighted the importance of a critical mass of multidisciplinary biological scientists working together.

"The CILR was formed in 2003 through the Australian Research Council (ARC) Centres of Excellence scheme to create the scale and focus required to build on existing research strengths through collaboration, and to be internationally competitive.

"ARC core funding and major support through Queensland Government Smart State research funding has been vital in building capacity. It has enabled this marvellous research outcome," Professor Gresshoff said.


Related medicine news :

1. Breathing Cancer Causing Compounds During Pregnancy Found To Affect Offspring
2. Compounds Found In The Vegetable Broccoli Could Have Anti-Cancer Properties
3. Adding Sorghum Compounds To Dietary Supplements May Help Lower Cholesterol
4. Sugars Could Contain Key Cancer Inhibiting Compounds
5. Five New Anti-Inflammatory Compounds Produced By Indian Scientists
6. Compounds in Licorice Can Fight Tooth Decay
7. Beans Devoid Of Flatulence Causing Compounds Would Soon Hit The Market
8. CLA Compounds Fight Diabetes
9. Two Chemical Compounds Restore Healthy Glucose Levels In Obese Mice
10. Breakthrough In The Identity Of Compounds That Encourage Stem Cell Growth
11. New Device Against Harmful Compounds in Air
Post Your Comments:

(Date:6/26/2016)... (PRWEB) , ... June 26, 2016 , ... Brent Kasmer, a legally blind and certified ... be personalized through a fitness app. The fitness app plans to fix the two major ... only offer a one size fits all type program , They don’t eliminate ...
(Date:6/25/2016)... California (PRWEB) , ... June 25, 2016 , ... "With ... fit their specific project," said Christina Austin - CEO of Pixel Film Studios. ... customizable and all within Final Cut Pro X . Simply select a ProHand ...
(Date:6/25/2016)... ... ... Conventional wisdom preaches the benefits of moderation, whether it’s a matter of indulgence ... high can result in disappointment, perhaps even self-loathing. However, those who set the bar ... from reveals that behind the tendency to set low expectations is ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Pulmonary Hypertension Association ... it will receive two significant new grants to support its work to advance ... 25th anniversary by recognizing patients, medical professionals and scientists for their work in ...
(Date:6/24/2016)... Plano, TX (PRWEB) , ... June 24, 2016 , ... ... taking part in Genome magazine’s Code Talker Award, an essay contest in which patients ... for an award to be presented at the 2016 National Society of Genetic Counselors ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... Tenn. , June 24, 2016  Arkis ... providing less invasive and more durable cerebrospinal fluid ... in funding.  The Series-A funding is led by ... Lighthouse Fund, and other private investors.  Arkis, new ... neurosurgical instrumentation and the market release of its ...
(Date:6/23/2016)... Research and Markets has announced ... Type (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic Chemical), Functionality ... - Global Forecast to 2021" report to their ... global pharmaceutical excipients market is projected to reach USD ... in the forecast period 2016 to 2021. ...
(Date:6/23/2016)... , June 23, 2016 ... CAPR ), a biotechnology company focused on the ... announced that patient enrollment in its ongoing randomized ... has exceeded 50% of its 24-patient target. Capricor ... the third quarter of 2016, and to report ...
Breaking Medicine Technology: